Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 1390861, 8 pages
http://dx.doi.org/10.1155/2016/1390861
Research Article

ALDH2 Inhibition Potentiates High Glucose Stress-Induced Injury in Cultured Cardiomyocytes

1Division of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Health System, Detroit, MI 48202, USA
2Department of Cardiovascular Sciences, Center for Cardiovascular Regeneration, Houston Methodist Research Institute, Houston, TX, USA
3Department of Physiology, Wayne State University, Detroit, MI 48202, USA

Received 20 April 2016; Revised 26 July 2016; Accepted 22 August 2016

Academic Editor: Kim Connelly

Copyright © 2016 Guodong Pan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Jackson, C. Brocker, D. C. Thompson et al., “Update on the aldehyde dehydrogenase gene (ALDH) superfamily,” Human Genomics, vol. 5, no. 4, pp. 283–303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. T. A. Doser, S. Turdi, D. P. Thomas, P. N. Epstein, S.-Y. Li, and J. Ren, “Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction,” Circulation, vol. 119, no. 14, pp. 1941–1949, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Harada, D. P. Agarwal, and H. W. Goedde, “Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese,” The Lancet, vol. 318, no. 8253, p. 982, 1981. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Brooks, M.-A. Enoch, D. Goldman, T.-K. Li, and A. Yokoyama, “The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption,” PLoS Medicine, vol. 6, no. 3, Article ID e1000050, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Suzuki, M. Taniyama, T. Muramatsu et al., “ALDH2/ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes,” Alcoholism: Clinical and Experimental Research, vol. 28, no. 8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. V. R. Mali and S. S. Palaniyandi, “Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease,” Free Radical Research, vol. 48, no. 3, pp. 251–263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. I. E. Blasig, T. Grune, K. Schonheit et al., “4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium,” The American Journal of Physiology, vol. 269, pp. H14–H22, 1995. View at Google Scholar
  9. J. Chen, G. I. Henderson, and G. L. Freeman, “Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 11, pp. 1919–1927, 2001. View at Publisher · View at Google Scholar
  10. A. L. Furfaro, S. Menini, S. Patriarca et al., “HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin,” BioFactors, vol. 24, no. 1–4, pp. 291–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Grune and K. J. A. Davies, “The proteasomal system and HNE-modified proteins,” Molecular Aspects of Medicine, vol. 24, no. 4-5, pp. 195–204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. B. G. Hill, B. P. Dranka, L. Zou, J. C. Chatham, and V. M. Darley-Usmar, “Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal,” The Biochemical Journal, vol. 424, no. 1, pp. 99–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Y. Lee, G. Y. Jung, H. J. Heo et al., “4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species,” Toxicology Letters, vol. 166, no. 3, pp. 212–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. V. B. Patel, C. H. Spencer, T. A. Young, M. O. Lively, and C. C. Cunningham, “Effects of 4-hydroxynonenal on mitochondrial 3-hydroxy-3-methylglutaryl (HMG-CoA) synthase,” Free Radical Biology and Medicine, vol. 43, no. 11, pp. 1499–1507, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. V. R. Mali, M. Deshpande, G. Pan, R. A. Thandavarayan, and S. S. Palaniyandi, “Impaired ALDH2 activity decreases the mitochondrial respiration in H9C2 cardiomyocytes,” Cellular Signalling, vol. 28, no. 2, pp. 1–6, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Watkins, G. M. Borthwick, and H. M. Arthur, “The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro,” In Vitro Cellular & Developmental Biology—Animal, vol. 47, no. 2, pp. 125–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. J. Stuck, M. Lenski, M. Böhm, and U. Laufs, “Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase,” The Journal of Biological Chemistry, vol. 283, no. 47, pp. 32562–32569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Tan, D.-B. Wang, X. Lu et al., “Doxorubicin induces apoptosis in H9c2 cardiomyocytes: role of overexpressed Eukaryotic translation initiation factor 5A,” Biological and Pharmaceutical Bulletin, vol. 33, no. 10, pp. 1666–1672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. V. R. Mali, R. Ning, J. Chen, X.-P. Yang, J. Xu, and S. S. Palaniyandi, “Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin,” Experimental Biology and Medicine, vol. 239, no. 5, pp. 610–618, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C.-H. Chen, G. R. Budas, E. N. Churchill, M.-H. Disatnik, T. D. Hurley, and D. Mochly-Rosen, “Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart,” Science, vol. 321, no. 5895, pp. 1493–1495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Selvakumar, M. J. Drescher, J. R. Dowdall et al., “CNGA3 is expressed in inner ear hair cells and binds to an intracellular C-terminus domain of EMILIN1,” Biochemical Journal, vol. 443, no. 2, pp. 463–476, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. S. Palaniyandi, Y. Nagai, K. Watanabe et al., “Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats,” Experimental Biology and Medicine, vol. 232, no. 9, pp. 1213–1221, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. L. Shen, J. J. Lipsky, and S. Naylor, “Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenase,” Biochemical Pharmacology, vol. 60, no. 7, pp. 947–953, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kumar, V. Kain, and S. L. Sitasawad, “High glucose-induced Ca2+ overload and oxidative stress contribute to apoptosis of cardiac cells through mitochondrial dependent and independent pathways,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1820, no. 7, pp. 907–920, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. W. Younce, K. Wang, and P. E. Kolattukudy, “Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP,” Cardiovascular Research, vol. 87, no. 4, pp. 665–674, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. S. Palaniyandi1, M.-H. Disatnik, L. Sun et al., “Aldehyde dehydrogenase activator attenuates diabetic cardiomyopathy; a role in improving the quality of resident cardiac stem cells?” The FASEB Journal, vol. 24, no. 1, supplement, p. 572.3, 2010. View at Google Scholar
  27. J. Wang, H. Wang, P. Hao et al., “Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats,” Molecular Medicine, vol. 17, no. 3-4, pp. 172–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M.-C. Desco, M. Asensi, R. Márquez et al., “Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol,” Diabetes, vol. 51, no. 4, pp. 1118–1124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. A. San Martín, P. Du, A. Dikalova et al., “Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2073–H2082, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Shen, Y. Li, Y. Li et al., “Rac1 is required for cardiomyocyte apoptosis during hyperglycemia,” Diabetes, vol. 58, no. 10, pp. 2386–2395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Gottlieb, S. M. Armour, M. H. Harris, and C. B. Thompson, “Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis,” Cell Death and Differentiation, vol. 10, no. 6, pp. 709–717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhang, S. A. Babcock, N. Hu, J. R. Maris, H. Wang, and J. Ren, “Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function,” BMC Medicine, vol. 10, article 40, 2012. View at Publisher · View at Google Scholar · View at Scopus